Somerville, MA, United States of America

Peter Corcoran


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Peter Corcoran

Introduction

Peter Corcoran is an accomplished inventor based in Somerville, MA (US). He has made significant contributions to the field of ocular health through his innovative research and patents. With a total of two patents to his name, Corcoran is recognized for his work in developing treatments for ocular diseases.

Latest Patents

Corcoran's latest patents focus on transient receptor potential cation channel subfamily M member 8 (TRPM8) antagonists and their methods of use. These inventions provide methods for treating or preventing ocular diseases or disorders in subjects. Specifically, they address ocular pain or discomfort by administering a composition that includes a pharmaceutically acceptable carrier and a pharmaceutically effective amount of a TRPM8 antagonist. In preferred embodiments, these methods target dry eye disease, showcasing Corcoran's commitment to improving ocular health.

Career Highlights

Peter Corcoran is currently associated with Ora Corporation, where he continues to advance his research and innovations. His work has garnered attention in the medical community, particularly for its potential to alleviate discomfort associated with ocular conditions.

Collaborations

Corcoran collaborates with notable colleagues, including Mark B Abelson and Keith Lane. Their combined expertise contributes to the development of effective treatments in the field of ocular health.

Conclusion

Peter Corcoran's contributions to ocular health through his innovative patents highlight his role as a leading inventor in the field. His work not only addresses significant medical needs but also paves the way for future advancements in ocular treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…